Face-tattooed tradie's very blunt message to people who are considering getting inked

Just great results during research

Pain-Free Ink removal

Test results

Face-tattooed tradie's very blunt message to people who are considering getting inked

MANCHESTER, LONDON, UNITED KINGDOM, October 25, 2021 /EINPresswire.com/ — A young tradie has blunt message to anyone considering the 'stupidity' of getting facial tattoos and to learn from the mistakes he made.

The TikTok user now regrets the distinctive ink markings on his face and has began the painstaking process of getting them removed.

He has shared his ordeal so far in a series of TikTok videos where he opened up on the swelling and 'worst pain ever' he's suffered to get the tattoos removed.

The first video warning everyone against facial tattoos has gone viral online with already with more than 145,000 views within two days.

'Next time any of you guys or ladies want to get f****** tattoos on your face and you later on regret because you want to be a boss of a big company or something, it's the worst f******pain ever,' the man, who goes by the name of Robbyn Banx explains.

He recommends numbing cream but says tattoo removal is still a painful experience.

'I also recommend don't get tattoos on your face because you're going to regret it later on, I'm telling you,' the tradie continues.

'Nobody would not regret it. Unless it's tribal, it's f***** stupidity.'

The man later shared footage of several facial tattoos covered in large bandages with a blunt message for anyone considering getting their face inked.

'They're really not cool,' the tattoo enthusiast said.

'They're really not noticeable, of course they are.'

'So if you don't walk around with a couple maxi pads slapped all over your face because you got stupid tattoos you regretted and want off when you realise they're dumb, don't f****** get them.'

The TikTok user then showed footage of his swollen face in a follow up video.

'So as you can see, it's nice and swollen, this is the s*** you're going to have to go through to get it off,' he explained.

Another video shows more footage of his swollen face drinking beer while watching his AFL team North Melbourne from home.

Keith Richardson
thINK
07041590083
email us here


Source: EIN Presswire

Biozek Medical Gaat Groen Met Zijn Nieuwste Productiefaciliteit

LAAN VAN DE RAM 49, 7324BW APELDOORN, THE NETHERLANDS, October 25, 2021 /EINPresswire.com/ — Met de voltooiing van zijn nieuwste productiefaciliteit, maakt Biozek Medical zijn belofte waar voor groene initiatieven en milieuvriendelijke productiepraktijken. Het bedrijfsteam van Biozek Medical had al eerder plannen ontwikkeld voor het verbeteren van de duurzaamheid van het milieu door het implementeren van maatregelen gericht op het voorkomen van vervuiling, het behoud van hulpbronnen, het verminderen en minimaliseren van afval, het elimineren van verontreinigende stoffen en het verminderen van de uitstoot van koolstofdioxide.

In een poging vervuiling te voorkomen heeft Biozek Medical een groot aantal productieprocessen gemoderniseerd en aangepast, hetgeen zal resulteren in een vermindering van de uitstoot. De nieuwste faciliteit zal veel besparingstechnieken voor het gebruik van minder water en energie bevatten die zij eerder al in andere faciliteiten hadden toegepast, zoals energie-efficiënte verlichting, software voor het beheer van hulpbronnen en efficiëntere productieapparatuur.

De productiefaciliteit van Biozek Medical maakt gebruik van milieuvriendelijke verpakkingen, met inbegrip van milieuvriendelijke inkten, heeft het gebruik van oceaangebonden plastics verminderd door middel van verantwoorde verpakkingspraktijken, en streeft naar "nul restafval naar stortplaats" door middel van meerdere afvalminimalisatiemethoden en het hergebruik van veel productiematerialen. Potentiële afvalproducten die tijdens de productie ontstaan zijn vloeistoffen, gassen en vaste stoffen. Biozek Medical heeft strategieën geïmplementeerd om de hoeveelheid geproduceerde afvalproducten te verminderen door te elimineren wat ze kunnen, te hergebruiken wat ze kunnen en te recyclen wat ze moeten weggooien. Tot de afvalbeperkingsstrategieën die tot op heden zijn geïmplementeerd behoren, maar zijn niet beperkt tot, het recyclen van schone lucht, aardgas en water, het gebruik van systemen voor hergebruik van water, het terugwinnen van productieoplosmiddelen voor hergebruik, en waar mogelijk het kopen van gerecyclede materialen. Afvalvermindering omvat het verminderen van de hoeveelheid werk die gemoeid is met het reinigen van productieapparatuur door gebruik te maken van geautomatiseerde schrobmachines, stoomreinigers en sonische reinigers, die ter plekke wassen en spoelen, waardoor het niet meer nodig is om de moeilijk te reinigen apparatuur te hanteren.

Biozek Medical blijft voortbouwen op haar vooruitgang in het verbeteren van milieuvriendelijke productieprocessen en erkent dat het belang van het nemen van beslissende maatregelen in de strijd tegen klimaatverandering een van de belangrijkste kwesties blijft waar bedrijven en gemeenschappen vandaag de dag mee te maken hebben.

Over Biozek Medical

Biozek Medical is een in Nederland gevestigd biotechnologiebedrijf dat bekend staat om het leveren van een breed scala aan innovatieve diagnostische oplossingen en diensten aan klanten over de hele wereld. Biozek is gespecialiseerd in het onderzoek naar en de ontwikkeling van in vitro diagnostische producten zoals point of care testkits, alsmede medische diagnostische en immunodiagnostische instrumenten. Door de combinatie van geavanceerde elektronische hulpmiddelen en de nieuwste snelle tests van Biozek, blijft het innovatieve oplossingen bieden voor de medische gemeenschap.

In de medische industrie wordt Biozek erkend als een bedrijf dat oplossingen biedt. Het levert kosteneffectieve en zeer nauwkeurige testproducten aan zijn klanten door samen te werken met de beste leveranciers van medische apparatuur. De toegenomen specialisatie van ziekenhuizen en medische faciliteiten, samen met de decentralisatie van ziekenhuizen, heeft Biozek in staat gesteld te profiteren van het gebruik van en de toegenomen belangstelling voor point of care testkits. Een van de doelstellingen van Biozek Medical is het produceren van goedkope, gemakkelijk te gebruiken producten om de levensverwachting en de toegang tot gezondheidszorg voor mensen in ontwikkelingslanden te helpen verbeteren.

Biozek wil de medische gemeenschap helpen de huidige pandemie doeltreffender aan te pakken en heeft daarom een aantal sneltests ontwikkeld, waaronder twee soorten COVID-19 Antigen sneltests, de ene met behulp van een neusswab en de andere met behulp van een niet-invasieve orale vloeistofmethode. Biozek heeft ook de COVID-19 antilichaam-sneltest ontwikkeld waarbij gebruik wordt gemaakt van serum- of plasmamonsters. De snelle tests van Biozek staan bekend om hun gebruiksgemak en hun snelle en zeer nauwkeurige resultaten. Biozek boort nieuwe techno-commerciële gebieden aan binnen de point of care testmarkt door het creëren van geïntegreerde technologische platforms en bedrijfsprocessen. In de jaren dat Biozek actief is, heeft het bedrijf zich ontwikkeld tot een wereldleider op het gebied van de productie van snelle tests en in-vitro diagnostische producten. Zijn kenmerkende COVID-19 snelle tests, evenals zijn tests voor een brede waaier van ziekten zoals dengue of syfilis, worden als wereldklasse beschouwd. Voor meer informatie, bezoek www.biozek.com

Mediacontact:
Samantha Cady
Covid Nieuws
s.cady@covidnews.com
BRON: Biozek

Samantha Cady
Covid Nieuws
email us here


Source: EIN Presswire

Natural Killer Cells Therapeutics Market Size to Gain Traction of $5.09 Billion Worth by 2026

Natural Killer Cells Therapeutics Market

Natural Killer Cells Therapeutics Market

Rise in use of NK cells for the treatment of infections & liver diseases, surge in awareness among the population regarding various immunotherapies, and increase in R&D for the development”

— Allied Market Research

PORTLAND, OR, UNITED STATES, October 25, 2021 /EINPresswire.com/ — Rise in use of NK cells for the treatment of infections & liver diseases, surge in awareness among the population regarding various immunotherapies, and increase in R&D for the development of bi-specific antibody for engaging NK cells to eliminate tumor cells propel the growth of the global NK cell therapeutics market. On the other hand, lack of specificity & poor in-vivo survival of the cells, higher costs associated with the therapies, and their adverse side effects restrain the growth of the market to some extent. However, significant surge in R&D activities toward development of immunotherapy in developing economies is anticipated to create lucrative opportunities in the near future.

Explore Report Description@ https://www.alliedmarketresearch.com/natural-killer-cell-therapeutics-market

"Natural Killer Cell Therapeutics Market by Therapeutics, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2018–2026." The report provides a detailed analysis of the drivers & opportunities, changing market trends, competitive market landscape, and market size & estimates. According to the report, the global NK Cell Therapeutics market was projected at $1.40 billion in 2018 and is expected to hit $5.09 billion by 2026, registering a CAGR of 17.4% during 2019–2026.

The NK cell-directed antibodies segment to lead the trail till 2026

Based on therapeutics, the NK cell-directed antibodies segment accounted for nearly three-fifths of the total market share in 2018 and is anticipated to rule the roost during the estimated period. Increase in usage of monoclonal antibodies for the treatment of various diseases and its easy availability spur the growth. At the same time, the NK cell therapies segment would grow at the fastest CAGR of 17.6% till 2026. Extensive research in developing NK cell therapeutics to treat cancer is the major factor driving the growth.

The cancer segment generated the highest growth in 2019-

Based on application, the cancer segment contributed to more than three-fourths of the total market revenue in 2018 and is expected to dominate through 2019–2026. This is attributed to significant increase in the prevalence of cancer in this region. The gastrointestinal diseases segment, on the other hand, is projected to grow at the fastest CAGR of 19.3% during the forecast period. This is attributed to the rising growth in geriatric population, and improvement in healthcare facilities in the province.

For Purchase Enquiry at : https://www.alliedmarketresearch.com/purchase-enquiry/2132

North America to be dominant by 2026-

Based on geography, North America held the major share in 2018, accounting for nearly half of the total market. Surge in the incidence of cancer in the region has driven the growth. At the same time, the Asia-Pacific region is predicted to showcase the fastest CAGR of 19.5% throughout the study period.

Frontrunners in the industry-

The key market players analyzed in the report include Affimed N.V., Altor BioScience Corporation, Chipscreen Biosciences, Ltd., NKT Therapeutics, Inc., Innate Pharma S.A., Sorrento Therapeutics Inc., NantKwest Inc., Bristol-Myers Squibb, Takeda Pharmaceutical Company Limited, and others. Incorporating a number of high-end strategies including expansions, mergers & acquisitions, partnerships, joint ventures, collaborations, and others, these market players have become able to heighten their stand in the industry.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

Trending Reports in Healthcare Industry:

Single Cell Analysis Market Global Research By 2030

Hearing Aids Market Global Research By 2030

Prostate Cancer Market Global Research By 2030

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts

David Correa
Allied Analytics LLP
+18007925285 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Getting to grips with granulation: a new eBook from Freeman Technology

Powder Flow Testing for Granulation Processes eBook Front Cover

Powder Flow Testing for Granulation Processes

An in-depth assessment of the application and value of powder flow testing in the optimisation of granulation processes.

TEWKESBURY, GLOUCESTERSHIRE, UK, October 25, 2021 /EINPresswire.com/ — A new eBook from Freeman Technology, a Micromeritics company and global leader in powder characterisation, explores the application of powder flow measurements for monitoring and optimising granulation processes. Granulation is a vital unit operation for many industries, notably the pharmaceutical sector, but endpoint detection and scale-up remain a challenge. ‘Powder Flow Testing for Granulation Processes’ focuses on the value of bulk powder characterisation within this context, notably dynamic powder testing, and includes a number of experimental studies highlighting the benefits it delivers. This latest addition to the Freeman literature library will be of interest to any scientist or engineer looking to apply granulation more efficiently, to manufacture products with the characteristics required for commercial success.

“Granulation underpins the performance of many commercial products, including foods, fertilisers and detergents,” said Jamie Clayton, Operations Director, Freeman Technology, “and important intermediates such as pharmaceutical tableting blends. However, optimisation remains a challenge for many powder processors. A defining distinction of dynamic testing is that it characterises granules via properties that correlate directly with performance, for example in a tablet press. It can therefore be used to set granule specifications that are independent of scale. This is an important benefit when it comes to scale-up and commercialisation.

Containing a wealth of information and presented in an easy-to-digest format, the new eBook includes:
– A discussion of motivations for granulation and how they affect which properties are most relevant for process monitoring.
– A review of alternative testing techniques for characterising granules, their strengths and limitations.
– Experimental studies highlighting the value of multi-faceted powder characterisation based on dynamic, shear and bulk powder property measurement.

"We’re delighted to add this new eBook to our library and share the expertise we’ve developed in this vital area,” said Mr Clayton. “We know that customers value our expanding range of eBooks for their detailed and comprehensive coverage in key areas. We hope the latest addition will be of considerable value to anyone facing a granulation challenge.”

Download a complimentary copy of Powder Testing for Granulation here – www.freemantech.co.uk/learn/ebooks

Terry Kelly
Micromeritics Instrument Corporation
+19545572966
email us here


Source: EIN Presswire

Leading Teeth Whitening Experts GLO Science® Announce All-New Product, AfterGLO

GLO Science AfterGLO Smile Boost

A Minty Gum Alternative, AfterGLO is the Next Generation of Breath Fresheners with Teeth Whitening Powers

Award-winning GLO Science is a New York City based oral health care company dedicated to delivering healthy and beautiful smiles.

A Minty Gum Alternative, AfterGLO is the Next Generation of Breath Fresheners with Teeth Whitening Power

AfterGLO is a new, dentist-formulated replacement to gum delivered in our patented G-Vial technology”

— GLO Science co-founder Stacey Levine

NEW YORK CITY, NEW YORK, USA, October 25, 2021 /EINPresswire.com/ — The next evolution of GLO-ing smiles and fresher breath is here – GLO Science, the award-winning oral care company that has transformed teeth whitening and oral health innovations to dental specialists and consumers, is thrilled to announce the launch of the brand’s freshest innovation: AfterGLO.

Designed to be used between brushings, AfterGLO’s safe-to-swallow, dentist-formulated gel instantly eliminates bad breath, kills harmful bacteria that cause cavities, and brightens smiles. Providing a whole-mouth clean, sparkling feeling instantly, each AfterGLO pack includes 15 vials and retails for $65 USD at www.sephora.com and www.gloscience.com.

“AfterGLO is a new, dentist-formulated replacement to gum delivered in our patented G-Vial technology,” shared co-founder Stacey Levine. “I like to keep the container on my desk and brush it on after coffee or before heading into a meeting.”

Formulated with natural antimicrobial ingredients and boasting a powerful mint flavor, AfterGLO is a sugar-free gum replacement that helps eliminate bad breath odor and keeps the mouth feeling clean. To use, simply remove the cap, squeeze a small bead of gel onto the applicator tip, and brush onto teeth to enjoy immediate long lasting fresh breath and a glowing, brighter smile. Like all other GLO Science products, AfterGLO is sugar free, gluten-free, cruelty- free, vegan, recyclable and made in the USA.

“We created a new way to boost your smile with good-for-your-mouth ingredients. AfterGLO is formulated and power-packed with natural antimicrobial ingredients that help promote good oral care, plus anti-gingivitis ingredients which inhibit the growth of bacteria that can cause cavities,” said Levine. “AfterGLO delivers fresh breath and a sparkling clean mouth. Now, that is something to smile about!”

AfterGLO is the perfect gum substitute for people with crowns, veneers, braces, and bridges. The safe-to-swallow dentist-formulated gel uses a low dose of hydrogen peroxide to instantly remove stains from food and drink while gradually continuing to whiten and brighten teeth. This serum is safe for smiles, providing clean fresh breath without sticking to teeth.

Levine adds, “Our brand is more than whiter teeth. We hope to empower everyone to harness the healing, liberating, invigorating power of their biggest, brightest, healthiest smile. Smiles have the power to make the world a happier place and we hope this AfterGLO encourages more people to smile more often.”

Bringing together breakthrough science and innovative design in beauty and oral health, GLO Science offers high-quality smile beauty and oral health products developed in the dental practice based on decades of clinical experience and scientific expertise. For more information on the new AfterGLO, the company, and for a full list of GLO Science products visit gloscience.com today.

Victoria Elder
GLO Science
+1 949-239-9220
email us here


Source: EIN Presswire

Are we nearing the end COVID-19 pandemic?

ZUG, ZUG, SUIZA, October 25, 2021 /EINPresswire.com/ — Those attending the Seventy-fourth World Health Assembly (WHA74) stressed the urgency of putting an end to the current pandemic, as well as preventing others by building a healthier, safer and fairer world. In this regard, Dr. Tedros Adhanom Ghebreyesus, General Director of the World Health Organization (WHO), stated that "a crisis often brings out the best in people and organizations" .

However, leading indicators of the Covid-19 pandemic signal that it is far from over. Among other factors, there is a disparity in access to vaccines, which poses a threat to efforts to contain the virus and its disease. More than 75 percent of the total doses have been administered in only 10 countries ; and in the lowest income countries, less than half of the global doses have been administered, that is, approximately 0.1 percent.

In this regard, the director of the Public Health and Environment department of the WHO, Maria Neira, has expressed that a favorable advance in global vaccination could become a pandemic regulator by March 2022 . The possibility of moderating or regulating through immunization implies accepting that COVID-19 will be part of our daily reality, infections or contagions will not be reduced in the short term, however, it may cease to be lethal.

For Latin America, the Pan American Health Organization (PAHO) has stressed that at this time it cannot predict whether this pandemic will end in 2022 or 2023, as it depends on vaccine coverage. In addition, the Economic Commission for Latin America and the Caribbean (ECLAC) has emphasized that the region will not be able to immunize 70 percent of its population with full immunization schemes, so it is important to support the exchange of knowledge in technology transfer and investment to substantially increase production.

In order to increase the viability of this scenario, it is essential to consider:
● The importance of having vaccines available, including those for children and teenagers.
● The need for outpatient and oral treatment against COVID-19, based on the announcements already known about the performance of antiviral pills.
● The availability of rapid, free and readily available tests to detect infection as early as possible.

According to Mike Ryan, executive director of the WHO's emergency program, threats of this type will continue, as pandemics are inevitable and the challenge of adapting to respond adequately requires a collective effort . Luis Doporto Alejandre, President of the Board of Directors of LATAM Pharma, indicates that “It is indisputable that research and distribution of immunization technologies and medicines among emerging countries is fundamental, and, for this reason, we have initiated our operations with the agreement that allows the filling and finishing of the CanSino vaccine for Latin America and the Caribbean”.

Press Release
LATAM Pharma Innovative Ventures AG
email us here


Source: EIN Presswire

Polycystic Ovarian Syndrome (PCOS) Treatment Market to Generate $4.18 Billion by 2026 | Growth & Key Business Strategies

Polycystic Ovarian Syndrome Treatments

The growth of the polycystic ovarian syndrome market is attributed to the rise in prevalence of PCOS disorders across the globe.

PORTLAND, OR, UNITED STATES, October 25, 2021 /EINPresswire.com/ — UPDATE AVAILABLE ON-DEMAND [Polycystic Ovarian Syndrome Treatment (PCOS) Market to Set New Growth Cycle]

The global polycystic ovarian syndrome treatment market size was valued at $ 2.90 billion in 2018, and is projected to reach $ 4.18 billion by 2026, growing at a CAGR of 4.7% from 2019 to 2026. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario.

Polycystic ovarian syndrome or PCOS is a hormonal disorder that occurs in women during their childbearing age and is characterized by formation of cyst on ovaries. PCOS often leads to hirsutism, obesity, infertility, and diabetes, thus, needs effective management. Presently, there is no cure for PCOS, but different types of medications, such as insulin sensitizing agent, oral contraceptive, antiandrogens, and anti-obesity drugs are used to manage PCOS.

Covid-19 Scenario:

1) The Covid-19 pandemic and followed by lockdown has affected several manufacturing industries.
2) The prolonged lockdown resulted in a disrupted supply chain and increased the prices of raw materials.
3) However, as the world has been recovering from the pandemic, the market is estimated to get back on track.

Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/6314

The polycystic ovarian syndrome treatment market is expected to experience significant growth during the forecast period owing to rise in demand for PCOS treatment medication across different regions and increase in popularity combination therapy majorly drives the market growth. Increase in prevalence of PCOS is expected to further boost the polycystic ovarian syndrome treatment market growth during the forecast period. In addition, significant unmet need for PCOS treatment, increase in R&D activities to develop PCOS therapeutics, and growing demand forof PCOS therapeutics in developing countries further creates opportunities for the PCOS treatment market. However, lack of approved drugs and adverse effects associated with off label drugs are anticipated to hamper the market growth.

On the basis of drug class, the market is categorized into insulin sensitizing agent, oral contraceptive, antiandrogens, anti-obesity drugs, and others. Presently, the insulin sensitizing agent segment is the major revenue contributing segment and is estimated to show a significant market growth during the forecast period, owing to higher adoption of insulin sensitizing agents as first line treatment in the management of PCOS.

According to distribution channel, the polycystic ovarian syndrome treatment market is classified into hospital pharmacies, drug stores & retail pharmacies, and online providers. The online providers segment is anticipated to depict significant growth during the forecast period, attributed to the rise in preference for online purchasing of drugs over traditional methods, increase in awareness of online pharmacy, and rise in number of internet users.

North America accounted for approximately one-half of the global polycystic ovarian syndrome treatment market share in 2018 and is expected to remain dominant throughout the forecast period. This was attributed to the rise in adoption of polycystic ovarian syndrome treatment medications, well developed healthcare infrastructure, large number of target population with higher health awareness, wide availability of advanced polycystic ovarian syndrome treatment therapeutics, and supportive reimbursement policies in the healthcare system. In addition, Asia-Pacific is expected to experience the highest growth rate during the forecast period majorly due to growing prevalence of PCOS, and increase in the adoption of polycystic ovarian syndrome treatment medication for the same.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/6314

The Major Key Players Are:

• Allergan plc.
• AstraZeneca plc.
• Bayer AG
• Bristol-Myers Squibb Company
• Johnson and Johnson
• Mylan N.V.
• Novartis AG
• Pfizer Inc.
• SANOFI
• Teva Pharmaceutical Industries.

Key Findings of the Study:

• Based on drug class, the insulin sensitizing agent segment held more than one half of share in the global market in 2018.
• Based on end user, the online providers segment exhibits fastest growth and is expected to grow at a CAGR of 6.3% from 2019 to 2026.
• Based on end user, the drug stores & retail pharmacies segment held the largest market share in 2018 and is expected to remain dominant throughout the forecast period.
• Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 6.3% during the forecast period.

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Nuclear Medicine Market Analysis, Industry Forecast, 2030

IVF Devices and Consumables Market Analysis, Industry Forecast, 2030

Biosurgery Market Analysis, Industry Forecast, 2030

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+18007925285 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

UAE’s K-12 education sector poised for growth

Coinciding with Expo 2020, the K-12 Education Show aligns with Dubai’s Urban Master Plan 2040 to nurture an expansion in education services in the emirate

DUBAI, UAE, October 25, 2021 /EINPresswire.com/ — Coinciding with Expo 2020, the K-12 Education Show aligns with Dubai’s Urban Master Plan 2040 to nurture an expansion in education services required to cater a population of up to 5.8 million Dubai residents by 2040

Student populations are on the rise
With the primary goal of making Dubai the best city in the world by enhancing quality of life for all residents, our government has announced a 25% increase in the land area allocated to education by 2040. Even looking as far as next year (2022), Dubai-based research firm Alpen Capital estimates that UAE will require 150 additional schools to accommodate its growing student population, which is expected to reach 1.5 million by then and will hike up enrolments in the K-12 sector throughout the country. Meanwhile, demand for private education is also being bolstered by an unprecedented hike in the influx of expats, brought about by recent government initiatives such as green visas and other business acceleration programmes which are attracting young, innovation-charged talent into the country.

Dubai welcomes 14,671 new school seats
Despite the Covid19 setback, 10 new schools have opened doors in Dubai during the 2021- 2022 academic calendar across diverse curricula including Indian (CBSE and ICSE), American, Australian, British and International Baccalaureate (IB). According to Knowledge and Human Development Authority (KHDA), Dubai enjoyed a 2.6% school enrolment growth between Sept 2020 and Feb 2021, which reflects its firm commitment to nurture a sustainable Knowledge Economy. All these growth trends point to Dubai’s booming school education sector which the upcoming K-12 Education Show will facilitate by bringing together the entire education community at one live, interactive marketplace event.

Post-Covid outlook for K-12 education
Commenting on a resilient post-Covid19 recovery and what it means for K-12 education services in UAE going forward, Managing Director at International Conferences & Exhibitions (show organiser of the K-12 Education Show by GETEX), Anselm Godinho says, “Learning from the Covid experience, UAE expats are keen to ensure that their children’s education is not disrupted going forward. Conversely, residential and day-scholar schools are looking for ways to pitch to expat parents with a clear message that they offer stable, comprehensive and quality education to children of ages 3 – 18, all at a price point that is competitive and affordable. We are proud and privileged to be offering the K-12 Education Show platform to parents so they are able to meet UAE’s education providers in person and make informed decisions for their children’s futures.”

K-12 Education Show at a glance
The K-12 Education Show by GETEX (Global Education and Training Exhibition) will be held at Dubai International Convention & Exhibition Centre from 23 – 25 Feb 2022 and will play a key role in informing, influencing and enrolling young learners. Taking place during Dubai’s 6-month long global mega-event, Expo 2020, it will attract between 10,000 – 15,000 potential students and their parents who will scout out the best study options and meet educators face to face to get their questions addressed. The event will host reputable nurseries, boarding schools, residential schools, special needs schools and all other education facilities catering to this sector.

The K-12 Education Show will also hold various onsite activations such as free-to-attend seminars, a Counsellors Forum and networking for education leaders. K-12 phase education providers looking to increase their student recruitment numbers who have not already slotted in their participation are welcome to enquire about exhibiting opportunities. Those unable to have a physical presence on the floor can book a virtual stand with audio visual access to students at the show.

For enquiries, please contact:
International Conferences & Exhibitions LLC
+971 4 3355001
info@icedxb.com

About the K-12 Education Show by GETEX:
GETEX (Global Education and Training Exhibition) has been the most powerful platform for education marketing in the Middle East since more than 30 years. It is the region’s leading student recruitment event connecting 400+ education providers to 35,000+ education seekers every year. The K-12 Education Show will be held alongside the upcoming Feb 2022 edition of GETEX, connecting young learners with schools operating across the UAE. For more information, please visit http://kto12educationshow.com/

Anselm Godinho
International Conferences & Exhibitions LLC
+971 4 335 5001
email us here


Source: EIN Presswire

FIGO calls on OBGYNs to help “mitigate the climate crisis affecting our patients and their families”

Image stating that the health impacts of climate change cannot be ignored.

The health impacts of climate change cannot be ignored.

tmage stating the impact of climate change and what. we can do

The impact of climate change and what. we can do

The International Federation of Gynecology and Obstetrics releases a call-to-action for OBGYNs to take a leadership role in the climate crisis.

The climate crisis has become a public health emergency that disproportionately affects pregnant people, children, those from disadvantaged and marginalised communities and people of colour.”

— Article authors – Linda C. Giudice et al

LONDON, UNITED KINGDOM, October 25, 2021 /EINPresswire.com/ — Leading up to the United Nations 2021 Climate Change Conference in Glasgow, Scotland, the International Federation of Gynecology and Obstetrics – which represents hundreds of thousands of maternal and child health care practitioners in more than 130 countries around the world – released a call-to-action on 25 October 2021, for obstetricians and gynaecologists (OBGYNs) to take a leadership role in the climate crisis saying, “The time to act is now.”

In a special article published online in the International Journal of Gynecology & Obstetrics, leading OBGYNs highlight the impact the climate crisis has on human reproduction and the fundamental risks it poses to the very continuation of our species. The authors, who wrote the article on behalf of the FIGO Committee on Climate Change and Toxic Environmental Exposures, highlight the role fossil fuels play in driving climate change and the need for government-driven and society-wide solutions to the crisis.

*Clear and present danger to humanity*
“The climate crisis has become a public health emergency that disproportionately affects pregnant people, children, those from disadvantaged and marginalised communities, people of colour, and human reproduction. As OBGYNs, we recognise that the climate crisis fundamentally risks the very continuation of our species,” the article states.

The authors review the latest science on how climate change-driven extreme weather displaces communities and families and leads to food and water insecurity, poor air quality, violence (including domestic violence, sexual abuse and trafficking) and disease – all of which put people’s health and sexual and reproductive health and rights at even greater risk. Climate change can also worsen maternity care and pregnancy outcomes in already low-resourced countries.

*Impact of climate crisis on pregnancy outcomes and fetal development*
Heat and air pollution exposures during pregnancy are linked to “increased risks of stillbirth, low birth weight, and preterm birth… and a significant increase in risk for fetal congenital anomalies,” the article states. “Some portions of the United States are anticipated to have up to a 60% increase in incidence of fetal congenital heart defects by 2035 due to heat exposure. Prenatal heat exposure has been linked to decreased cognitive ability and diminished adult earnings.” The authors also detail the increased risks natural disasters such as flooding and hurricanes pose to women, children and pregnant people, including higher exposure to harmful pollutants and chemicals linked to maternal hypertensive disease, depression, pre-eclampsia, post-traumatic stress and premature birth.

*Climate change exacerbates exposures to toxic chemicals*
The authors explain how extreme weather can release harmful chemicals and exacerbate the health impacts of air pollution, especially for low-income communities of colour. In addition, it highlights how fossil fuels not only drive climate change, but petroleum and natural gas are ingredients for plastics and other consumer products that contain phthalates, flame retardant chemicals, and PFAS (per- and polyfluoroalkyl substances) – all endocrine-disrupting chemicals that can increase the risk of adverse health effects.

“Production of these chemicals have steadily increased since the 1950s and corresponds to a dramatic increase in health problems affecting women and their families such as diabetes, fertility problems, cancer, and neurodevelopmental disorders,” the article states.

*Disproportionate impacts increase inequalities*
The groups who experience the greatest environmental injustices are typically least responsible for climate change emissions and are disproportionately women, people of colour and marginalised communities.

“Women are especially hard-hit, with decreased life expectancy from natural disasters, increased incidence of depression, anxiety and post-traumatic stress, and diminished access to health care to treat conditions as diverse as anaemia, malnutrition, menstrual difficulties, and urinary tract infections,” the article states. The authors also explain how climate change contributes to higher rates of sexual exploitation and greater challenges to accessing contraception and reproductive rights, which amplify underlying disparities that exist.

*OBGYNS are needed to advocate society-wide solutions*
Individual efforts to combat climate change, while “commendable,” are “insufficient” when the fossil fuel industry is a major driver, the authors say. “As health care providers, we need to understand the science underlying the effects of climate change on women’s health and advocate for governments to implement policies that address and reduce the root causes of climate change.”

Article: “Climate change, women’s health, and the role of obstetricians and gynecologists in leadership” (Giudice L, Llamas-Clark EF, DeNicola N, et al. Int J Gynecol Obstet 2021;155. Doi: 10.1002/ijgo.13958.)

Authors: On behalf of the FIGO Committee on Climate Change and Toxic Environmental Exposures: Linda C. Giudice, chair, FIGO Committee on Climate Change and Toxic Environmental Exposures and University of California, San Francisco (UCSF); Erlidia F. Llamas-Clark,, University of the Philippines – Philippine General Hospital; Nathaniel DeNicola, Johns Hopkins Health System; Santosh Pandipati, Obstetrix Medical Group/Mednax; Marya G Zlatnik, Program on Reproductive Health and the Environment, UCSF; Ditas Cristina D Decena, University of Santo Tomas; Tracey J. Woodruff, Program on Reproductive Health and the Environment and Environmental Research and Translation for Health (EaRTH) Center, UCSF; Jeanne A. Conry, FIGO President-Elect and President and CEO, Environmental Health Leadership Foundation

– Ends –

*About the International Federation of Gynecology and Obstetrics (FIGO)*
FIGO is a professional organisation that brings together more than 130 obstetrical and gynaecological associations from all over the world. FIGO’s vision is that women of the world achieve the highest possible standards of physical, mental, reproductive and sexual health and wellbeing throughout their lives. We lead on global programme activities, with a particular focus on sub-Saharan Africa and South East Asia.

FIGO advocates on a global stage, especially in relation to the Sustainable Development Goals (SDGs) pertaining to reproductive, maternal, newborn, child and adolescent health and non-communicable diseases (SDG3). We also work to raise the status of women and enable their active participation to achieve their reproductive and sexual rights, including addressing female-genital mutilation (FGM) and gender-based violence (SDG5).

We also provide education and training for our Member Societies and build capacities of those from low-resource countries through strengthening leadership, good practice and promotion of policy dialogues. FIGO is in official relations with the WHO and consultative status with the United Nations.

Rob Hucker
International Federation of Gynecology and Obstetrics
+44 7383025731
communications@figo.org
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

New Study Underlines Significance of Damiva’s Quest to Fight Body Pollution

Always 100% Natural Damiva Products

Always 100% Natural

Always Chemical-Free Damiva Products

Chemical-Free, Always

Paraben and Phthalate Free Damiva Products

Paraben and Phthalate Free, Always

People with the highest amounts of phthalates have a 48% increase in mortality. Damiva pledges to keep these toxic chemicals out of formulations, forever.

We are on a quest to fight body pollution by developing 100% natural fem care and skin care products that can be used by women at any stage of life.”

— Chia Chia Sun

TORONTO, ONTARIO, CANADA, October 25, 2021 /EINPresswire.com/ — The latest study of over 5,000 men and women in the U.S. between the ages of 55 and 64 provides further evidence that phthalates are polluting bodies and leading to 48% increase in risk of death. “Everywhere” and “forever” chemicals are unfortunately here to stay including in the environment and people’s bodies. Damiva, the Always 100% NaturalTM product company, commits to developing products that will not contribute to the chemical overload crisis.

Toxic chemicals in consumer products are ubiquitous and difficult to excrete once ingested or absorbed through skin. The new data from Dr. Leonardo Trasande of NYU Langone Health demonstrates that there is an association between high levels of phosphates in urine and early death, leading to approximately 100,000 premature deaths in the U.S. on an annual basis.

“The issue is,” says Annette Garcea, Health & Wellness Lead at Damiva, “that the climate change and body pollution crises are linked. These chemicals we are using are not only polluting our environment, they are also staying in our bodies and making us sick.”

Free of chemical preservatives, foaming agents and stabilizers – such as phthalates, sulfates, sulfides and glycerin – and also free of fragrances, Damiva’s patented processes for developing and manufacturing chemical-free products includes removing water that provides the basis for bacterial growth.

“We are on a quest to fight body pollution by developing 100% natural fem care and skin care products that can be used by women at any stage of life,” says Chia Chia Sun, CEO of Damiva. “We want to be a significant part of the solution to removing the toxic chemical overload that women are experiencing from their consumer products.”

To learn more about how Damiva is leading in combatting body pollution, watch this video:

Chia Chia Sun
Damiva Inc.
email us here
Visit us on social media:
Facebook
Twitter

Watch Out for the #1 Enemy


Source: EIN Presswire